A Global Skin Biopsy Market Size study & Forecast, by Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy), by Indication (Skin cancer

Global Skin Biopsy Market Size study & Forecast, by Type (Shave Biopsy, Punch Biopsy, Excisional Biopsy), by Indication (Skin cancer, Actinic keratosis, Dermatitis, Others), by End-User (Hospital and Clinics, Diagnostic Laboratories, Other) and Regional Analysis, 2022-2029

Global Skin Biopsy Market is valued at approximately USD 0.101 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 6 % over the forecast period 2022-2029. Skin biopsy is a technology used in diagnosis of skin cancer as well as other skin disorders such as actinic keratosis, dermatitis, psoriasis, and others. A skin biopsy is removing a sample of skin from the skin lesion or infection and examining it under a microscope to look for cancerous cells. This procedure not only serves as a skin cancer diagnostic tool, but it also sometimes might help treat cancer by completely removing malignant cells. Additionally, because the procedure is less intrusive, it causes fewer skin incisions and shorter healing times. Due to the benefits that skin biopsy provides, this technique is therefore often used to diagnose skin cancer. The expansion of the skin biopsy market size is expected to be fueled by high potential in untapped, emerging economies, due to availability of improved healthcare facilities, enhancement of unmet healthcare needs, rise in the number of skin cancer cases, and rise in demand for advanced healthcare facilities. Additionally, the market is expanding due to an increase in skin cancer cases. Due to many factors, such as changes in lifestyle and environmental conditions, there has been a significant increase in cancer diagnoses worldwide during the past decade that is anticipated to support the market growth during forecast period.

Moreover, rise in skin cancer cases will consequently boost the growth of skin biopsy as a diagnostic procedure and push skin biopsy market growth. For instance, the American Academy of Dermatology Association estimates that more than 1 million Americans had melanoma as of 2022 and those 197,700 new cases of the disease 97,920 noninvasive and 99,780 invasive were identified in the country that year. This draws attention to the anticipated rise in skin cancer cases in the United States over the coming years, which raises the need for biopsy for diagnostic purposes. Additionally, skin cancer diagnoses exceed those for breast, lung, prostate, and colon cancer in the United States each year. This fuels the market for skin biopsies to grow. Additionally, rising adoption of minimally invasive procedures is anticipated to create lucrative opportunities for the market during forecast period. However, the high cost of skin biopsy procedures and presence of new alternatives to skin biopsies stifle market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Skin Biopsy Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the presence of key market players, advancement in manufacturing technology of skin biopsy products, and rising prevalence of skin cancer. Whereas, Asia Pacific is also anticipated to exhibit the highest growth rate over the forecast period, owing to factors such as rising healthcare spending, growing awareness regarding skin health and its diagnosis and treatment procedures in the region would create lucrative growth prospects for the Skin Biopsy market across Asia Pacific region.

Major market players included in this report are:
AccuTec, Inc.
Cardinal Health Inc.
Innovia Medical
Jai Surgicals Ltd.
Integra LifeSciences
Vernacare
Becton Dickinson and Company
KAI Group
Paramount Surgimed Limited
World Precision Instruments

Recent Developments in the Market:
In July 2022, the platforms developed by Siemens Healthineers and Intuitive for a robotic-assisted platform for noninvasive lung biopsies were approved by the FDA. During processes, the integration would enable 2D and 3D imaging.

Global Skin Biopsy Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Indication, End-User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type:
Shave Biopsy
Punch Biopsy
Excisional Biopsy

By Indication:
Skin cancer
Actinic keratosis
Dermatitis
Others

By End-User:
Hospital and Clinics
Diagnostic Laboratories
Other

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

AccuTec, Inc.
Cardinal Health Inc.
Innovia Medical
Jai Surgicals Ltd.
Integra LifeSciences
Vernacare
Becton Dickinson and Company
KAI Group
Paramount Surgimed Limited
World Precision Instruments

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.